These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 37118799)

  • 1. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
    Mansoor M; Foreman-Mackey A; Ivsins A; Bardwell G
    Harm Reduct J; 2023 Apr; 20(1):61. PubMed ID: 37118799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes.
    Bardwell G; Ivsins A; Mansoor M; Nolan S; Kerr T
    CMAJ; 2023 May; 195(19):E668-E676. PubMed ID: 37188370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study.
    Ivsins A; Boyd J; Mayer S; Collins A; Sutherland C; Kerr T; McNeil R
    Drug Alcohol Depend; 2020 Nov; 216():108202. PubMed ID: 32948372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada.
    Norton A; Ivsins A; Holliday E; Sutherland C; Kerr T; Kennedy MC
    Int J Drug Policy; 2024 Sep; 131():104547. PubMed ID: 39159532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons for Enrolling in Safer Supply Programs: A Longitudinal Qualitative Study on Participant Goals and Related Outcomes in the MySafe Program.
    Ivsins A; Mansoor M; Bowles J; Bardwell G
    J Stud Alcohol Drugs; 2024 Nov; 85(6):845-855. PubMed ID: 38900057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safer opioid supply: qualitative program evaluation.
    Haines M; O'Byrne P
    Harm Reduct J; 2023 Apr; 20(1):53. PubMed ID: 37081500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "If it wasn't for them, I don't think I would be here": experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis.
    Kolla G; Pauly B; Cameron F; Hobbs H; Ranger C; McCall J; Majalahti J; Toombs K; LeMaistre J; Selfridge M; Urbanoski K
    Harm Reduct J; 2024 Jun; 21(1):111. PubMed ID: 38849866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "The machine doesn't judge": Counternarratives on surveillance among people accessing a safer opioid supply via biometric machines.
    Bardwell G; Ivsins A; Wallace JR; Mansoor M; Kerr T
    Soc Sci Med; 2024 Mar; 345():116683. PubMed ID: 38364722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "It's Helped Me a Lot, Just Like to Stay Alive": a Qualitative Analysis of Outcomes of a Novel Hydromorphone Tablet Distribution Program in Vancouver, Canada.
    Ivsins A; Boyd J; Mayer S; Collins A; Sutherland C; Kerr T; McNeil R
    J Urban Health; 2021 Feb; 98(1):59-69. PubMed ID: 33118145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribed safer supply during dual public health emergencies: a qualitative study examining service providers perspectives on early implementation.
    McCall J; Hobbs H; Ranger C; Cameron F; Stuart H; Nelken J; Majalahti J; Urbanoski K; Kolla G; LeMaistre J; Toombs K; Herriot R; Pauly B
    Subst Abuse Treat Prev Policy; 2024 Mar; 19(1):19. PubMed ID: 38444035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling the overdose crisis: The role of safe supply.
    Ivsins A; Boyd J; Beletsky L; McNeil R
    Int J Drug Policy; 2020 Jun; 80():102769. PubMed ID: 32446183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons Learned from Implementation of a Post-opioid Overdose Outreach Program in a Rural Massachusetts Community.
    Senthilkumar R; Bailey A; Moner E; Parduhn T; Evans EA
    Community Ment Health J; 2024 Apr; 60(3):482-493. PubMed ID: 37902945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation opportunities and challenges to piloting a community-based drug-checking intervention for sexual and gender minority men in Vancouver, Canada: a qualitative study.
    Coulaud PJ; Chayama KL; Schwartz C; Purdie A; Lysyshyn M; Ti L; Knight R
    Harm Reduct J; 2024 Apr; 21(1):87. PubMed ID: 38678256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs.
    Reed MK; Salcedo VJ; Guth A; Rising KL
    J Subst Abuse Treat; 2022 Sep; 140():108790. PubMed ID: 35577663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
    Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G
    J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis.
    Karamouzian M; Rafat B; Kolla G; Urbanoski K; Atkinson K; Bardwell G; Bonn M; Touesnard N; Henderson N; Bowles J; Boyd J; Brunelle C; Eeuwes J; Fikowski J; Gomes T; Guta A; Hyshka E; Ivsins A; Kennedy MC; Laurence G; Martignetti L; Nafeh F; Salters K; Tu D; Strike C; Pauly B; Werb D
    Int J Drug Policy; 2023 Oct; 120():104157. PubMed ID: 37574645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada.
    Glegg S; McCrae K; Kolla G; Touesnard N; Turnbull J; Brothers TD; Brar R; Sutherland C; Le Foll B; Sereda A; Goyer MÈ; Rai N; Bernstein S; Fairbairn N
    Int J Drug Policy; 2022 Aug; 106():103742. PubMed ID: 35679695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "You can see those concentric rings going out": Emergency personnel's experiences treating overdose and perspectives on policy-level responses to the opioid crisis in New Hampshire.
    Saunders E; Metcalf SA; Walsh O; Moore SK; Meier A; McLeman B; Auty S; Bessen S; Marsch LA
    Drug Alcohol Depend; 2019 Nov; 204():107555. PubMed ID: 31542630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'I don't chase drugs as much anymore, and I'm not dead': Client reported outcomes associated with safer opioid supply programs in Ontario, Canada.
    Schmidt RA; Kaminski N; Kryszajtys DT; Rudzinski K; Perri M; Guta A; Benoit AC; Bayoumi AM; Challacombe L; Hales J; Kenny K; Kolla G; O'Reilly E; Sereda A; Rai N; Strike C
    Drug Alcohol Rev; 2023 Nov; 42(7):1825-1837. PubMed ID: 37718646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.